SEC Form D · filed September 21, 2022
Syros Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (39)
Marsha A. Fanucci · Cambridge, MADirectorPeter Wirth · Cambridge, MADirectorRichard A. Young · Cambridge, MADirectorSrinivas Akkaraju · Cambridge, MADirectorSue G. Eckhardt · Cambridge, MADirectorDavid C. Roth · Cambridge, MAExecMark Alles · Cambridge, MADirectorNancy Simonian · Cambridge, MAExec · DirectorEric C. Olson · Cambridge, MAExecPierre H. Lecomte · LARKSPUR, CADirectorCharles Esserman · LARKSPUR, CADirectorJennifer B. Moser · LARKSPUR, CADirectorIrena D. Blind · LARKSPUR, CAExecDrew D. Weilbacher · LARKSPUR, CADirectorWilliam D. Cooling · LARKSPUR, CADirectorJames L. O'Hara · LARKSPUR, CADirectorM. H. Mullin · LARKSPUR, CAExec · DirectorEdward D. Wong · LARKSPUR, CAExecTimothy C. Tyson · GREENWICH, CTDirectorDeborah Dunsire · Cambridge, MADirectorKristin C. Stephens · Cambridge, MAExecConely C. Chee · Cambridge, MAExecJason C. Haas · Cambridge, MAExecAndrew C. Oh · Cambridge, MADirectorJoon Chang · Stamford, CTDirectorTyler Stowater · Colmbus, OHDirectorPeter Valenti · Colmbus, OHDirectorBrad Beasecker · Columbus, OHDirectorRichard Lindstrom · Columbus, OHExecRichard Heinick · Columbus, OHExecRobin Sears · Columbus, OHDirectorJoseph H. Coyne · Dripping Springs, TXExec · DirectorScott Birnbaum · New York, NYDirectorTimothy C. Tyson · New York, NYDirectorDeborah Dunsire · Cambridge, MADirectorKristin C. Stephens · Cambridge, MAExecConely C. Chee · Cambridge, MAExecJason C. Haas · Cambridge, MAExecAndrew C. Oh · Cambridge, MADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗